Tag: Etelcalcetide

For many patients, cinacalcet is an effective treatment for hyperparathyroidism, but clinical studies and anecdotal reports show a significant incidence of gastrointestinal side effects, prompting the need for alternatives. Understanding the available treatment options is crucial for achieving optimal management of the condition, especially in those with chronic kidney disease (CKD).

Between 25% and 66% of patients taking cinacalcet report significant gastrointestinal side effects, such as nausea and vomiting, leading many to seek alternative treatments. Deciding what can be used instead of cinacalcet is a complex process that depends on the specific type of hyperparathyroidism, patient tolerance, and other co-existing medical conditions.